您当前的位置:
首页 >
文章列表页 >
Compound Glycyrrhizin Tablets Ameliorate Liver Injury Induced by Tripterygium Glycosides Tablet by Regulating Cholesterol Metabolism
更新时间:2024-12-24
    • Compound Glycyrrhizin Tablets Ameliorate Liver Injury Induced by Tripterygium Glycosides Tablet by Regulating Cholesterol Metabolism

    • The latest research has found that Tripterygium wilfordii Hook. f. polysaccharide tablets can cause liver damage by affecting cholesterol metabolism, and compound glycyrrhizin tablets can alleviate its toxicity.
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 2, Pages: 46-55(2025)
    • DOI:10.13422/j.cnki.syfjx.20241421    

      CLC: R575;R285;R256
    • Published:20 January 2025

      Published Online:03 June 2024

      Received:24 January 2024

    移动端阅览

  • FU Xiaotong,CAO Chunyu,LI Chun,et al.Compound Glycyrrhizin Tablets Ameliorate Liver Injury Induced by Tripterygium Glycosides Tablet by Regulating Cholesterol Metabolism[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(02):46-55. DOI: 10.13422/j.cnki.syfjx.20241421.

  •  
  •  

0

Views

2

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Effect of Danhe Granules on Hypercholesterolemia Rats Based on Cholesterol Metabolism Pathway-related Proteins
Effect of Modified Dahuang Huanglian Xiexintang on Oxidative Stress Injury of Liver in Type 2 Diabetes Mellitus Rats Based on Nrf2/HO-1 Axis
Exploring Detoxication Mechanism of Dioscoreae Bulbiferae Rhizoma Processed with Phaseoli Radiati Semen Juice Based on Target Organ Ferroptosis

Related Author

CAO Chunyu
LI Chun
LU Chenna
ZHAO Minghong
LU Tianming
LIU Li
WANG Qixin
YANG Tong

Related Institution

Gannan Medical University
Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
School of Public Health, Guangxi Medical University
Institute of Scientific Research,Beijing Tongrentang Company Limited by Shares
School of Chinese Materia Medica,Beijing University of Chinese Medicine
0